Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: Decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5177-5183

  Van Der Veen, Roel C ^a   Dietlin, Therese A ^a   Hofman, Florence M ^a   Pen, Ligaya ^a   Segal, Brahm H ^b   Holland, Steven M ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE RESISTANCE; ENZYME ACTIVITY; ENZYME INHIBITION; HELPER CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034658353     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5177     Document Type: Article

References (45)

1. Langermans, J. A. M., M. E. B. van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and R. van Furth. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J. Immunol. 148:568.
2. Imai, T., Y. Hirata, K. Kanno, and F. Marumo. 1994. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93:543.
3. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe-Seyler 373:897.
4. Merrill, J. E., L. J. Ignarro, M. P. Sherman, J. Melinek and T. E. Lane. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:2132.
5. Ding, M., M. Zhang, J. L. Wong, N. E. Rogers, L. J. Ignarro, and R. R. Voskuhl. 1998. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160: 2560.
6. Bagasra, O., F. H. Michaels, Y. M. Zheng, L. E. Bobroski, S. V. Spitsin, Z. F. Fu, R. Tawadros, and H. Koprowski. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:12041.
7. Bo, L., T. M. Dawson, S. Wesselingh, S. Mork, S. Choi, P. A. Kong, D. Hanley and B. D. Trapp. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778.
8. Cross, A. H., T. P. Misko, R. F., Lin, W. F. Hickey, J. L. Trotter and R. G. Tilton. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 91:2684.
9. Zhao, W., R. G. Tilton, J. A. Corbett, M. L. McDaniel, T. P. Misko, J. R. Williamson, A. H. Cross, and W. F. Hickey. 1996. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:123.
10. Hooper, D. C., S. T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, and H. Koprowski. 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc: Natl. Acad. Sci. USA 92:5312.
11. Misko, T. P., J. L. Trotter, and A. H. Cross. 1995. Mediation of inflammation by encephalitogenic cells: interferon γ induction of nitric oxide synthase and cyclo-oxygenase 2. J. Neuroimmunol. 61:195.
12. Mitrovic, B., L. J. Ignarro, S. Montestruque, A. Smoll and J. E. Merrill. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575.
13. Zielasek, J., S. Jung, R. Gold, F. Y. Liew, K. V. Toyka, and H. P. Hartung. 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58: 81.
14. Ruuls, S. R., S. van der Linden, K. Sontrop, I. Huitinga and C. D. Dijkstra. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:467.
15. Gold, D. P., K. Schroder, H. C. Powell and C. J. Kelly. 1997. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:2863.
16. Cowden, W. B., F. A. Cullen, M. A. Staykova, and D. O. Willenborg. 1998. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1.
17. Hogg, N., B. Kalyanaraman, and V. Darley-Usmar. 1995. Oxidant and antioxidant effects of nitric oxide and superoxide in the vasculature. In The Oxygen Paradox. K. J. A. Davies and F. Ursini, eds. Cleup University Press, Padora, Italy, p. 317-324.
18. Matthys, P., G. Froyen, L. Verdot, S. Huang, H. Sobis, J. Van Damme, B. Vray, M. Aguet, and A. Billiau. 1995. IFN-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J. Immunol. 155:3823.
19. Kubes, P., I. Kurose, and D. N. Granger. 1994. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 267:H931.
20. Mills, C. D. 1991. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:2719.
21. Tomioka, H., and H. Saito. 1991. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J. Leukocyte Biol. 51:24.
22. Albina, J. E., J. A. Abate, and W. L. Henry, Jr. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:144.
23. Krenger, W., G. Falzarano, J. Delmonte, Jr., K. M. Snyder, J. C. Byon, and J. L. Ferrara. 1996. Interferon-γ suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood 88:1113.
24. Togashi, H., M. Sasaki, E. Frohman, E. Taira, R. R. Ratan, T. M. Dawson, and V. L. Dawson. 1997. Neuronal (type 1) nitric oxide synthase regulates nuclear NFkB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA 94:2676.
25. Sahrbacher, U. C., F. Lechner, H. P. Eugster, K. Frei, H. Lassmann, A. Fontana. 1998. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28: 1332.
26. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnen, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:2940.
27. Beckman, J. S., Y. Z .Ye, P. G. Anderson, J. Chen, M. A. Accavitti, M. M. Tarpey, and C. R. White. 1994. Extensive nitration of protein tyrosines in human atherosclerosis, detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375:81.
28. Radi, R. J. S. Beckman, K. M. Bush, and B. A. Freeman. 1991, Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:481.
29. van der Veen, R. C., and L. J. Roberts. 1999. Contrasting roles for nitric oxide and peroxynitrite in ehe peroxidation of myelin lipids. J. Neuroimmunol. 95:1.
30. Zingarellli, B., M. O'Connor, H. Wong, A. L. Salzman, and C. Szabo. 1996. Peroxynitrite-mediated DNA stand breakage activates polyadenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156:350.
31. Hooper, D. C., O. Bagasra, J. C. Marini, A. Zborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobroski, J.-L. Farber, et al. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94:2528.
32. van der Veen, R. C., D. R. Hinton, F. Incardonna, F. M. Hofman. 1997. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1.
33. Cross, A. H., P. T. Manning, M. K. Stern, and T. P. Misko. 1997. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol. 80:121.
34. van der Veen, R. C., T. A. Dietlin, L. Pen and J. D. Gray. 1999. Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion. Cell. Immunol. 193:194.
35. phox mouse knockout model of chronic granulomatous disease. J. Exp. Med. 182:751.
36. van der Veen, R. C., P.-J. Chen, and M. McMillan. 1995. Myelin proteolipid protein-induced Th1 and Th2 clones express TCR with similar fine specificity for peptide and CDR3 homology despite diverse Vβ usage. Cell. Immunol. 166:291.
37. van der Veen, R. C., and S. A. Stohlman. 1993. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:213.
38. Gryglewski, R. J., R. M. J. Palmer, and S. Moncada. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454.
39. Grisham, M. B., D. Jourd'heuil, and D. A. Wink. 1999. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276:G315.
40. Clancy, R. M., J. Leszczynska-Piziak, and S. B. Abramson. 1992. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90:1116.
41. Hogg, N., B. Kalyanaraman, J. Joseph, A. Sruck, and S. Parthasarathy. 1993. Inhibition of low-density lipoprotein oxidation by nitric oxide. Fed. Eur. Biochem. Soc. 334:170.
42. Jessup, W., D. Mohr, S. P. Giese, R. T. Dean, and R. Stocker. 1992. The participation of nitric oxide in cell-free and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim. Biophys. Acta 1180:73.
43. Brito, C., M. Naviliat, A. C. Tiscornia, F. Vuillier, G. Gualco, G. Dighiero, R. Radi, and A. M. Cayota. 1999. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J. Immunol. 162:3356.
44. van der Veen, R. C., T. A. Dietlin, J. D. Gray, and W. Gilmore. 2000. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell. Immunol. 199:43.
45. + nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Cell. Immunol. 189:149.